RhumbLine Advisers’s Utah Medical Products UTMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $325K | Buy |
|
|||||
|
2025
Q1 | $289K | Sell |
|
|||||
|
2024
Q4 | $369K | Sell |
|
|||||
|
2024
Q3 | $445K | Buy |
|
|||||
|
2024
Q2 | $368K | Buy |
|
|||||
|
2024
Q1 | $334K | Buy |
|
|||||
|
2023
Q4 | $382K | Sell |
|
|||||
|
2023
Q3 | $398K | Buy |
|
|||||
|
2023
Q2 | $419K | Sell |
|
|||||
|
2023
Q1 | $434K | Buy |
|
|||||
|
2022
Q4 | $452K | Buy |
|
|||||
|
2022
Q3 | $374K | Buy |
|
|||||
|
2022
Q2 | $353K | Sell |
|
|||||
|
2022
Q1 | $413K | Sell |
|
|||||
|
2021
Q4 | $499K | Sell |
|
|||||
|
2021
Q3 | $468K | Buy |
|
|||||
|
2021
Q2 | $414K | Buy |
|
|||||
|
2021
Q1 | $386K | Sell |
|
|||||
|
2020
Q4 | $389K | Buy |
|
|||||
|
2020
Q3 | $340K | Sell |
|
|||||
|
2020
Q2 | $433K | Buy |
|
|||||
|
2020
Q1 | $448K | Hold |
|
|||||
|
2019
Q4 | $514K | Buy |
|
|||||
|
2019
Q3 | $454K | Buy |
|
|||||
|
2019
Q2 | $446K | Sell |
|
|||||
|
2019
Q1 | $412K | Buy |
|
|||||
|
2018
Q4 | $386K | Buy |
|
|||||
|
2018
Q3 | $289K | Sell |
|
|||||
|
2018
Q2 | $360K | Buy |
|
|||||
|
2018
Q1 | $309K | Sell |
|
|||||
|
2017
Q4 | $261K | Sell |
|
|||||
|
2017
Q3 | $280K | Sell |
|
|||||
|
2017
Q2 | $281K | Sell |
|
|||||
|
2017
Q1 | $268K | Buy |
|
|||||
|
2016
Q4 | $302K | Sell |
|
|||||
|
2016
Q3 | $281K | Buy |
|
|||||
|
2016
Q2 | $289K | Buy |
|
|||||
|
2016
Q1 | $249K | Buy |
|
|||||
|
2015
Q4 | $225K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $207K | Sell |
|
|||||
|
2015
Q1 | $220K | Buy |
|